Adults Hospitalized with Pneumonia in the United States: Incidence, Epidemiology, and Mortality

Clinical Infectious Diseases

Volumn 65, Issue 11, 2017, Pages 1806-1812

  Ramirez, Julio A ^a   Wiemken, Timothy L ^a   Peyrani, Paula ^a   Arnold, Forest W ^a   Kelley, Robert ^a   Mattingly, William A ^a   Nakamatsu, Raul ^a   Pena, Senen ^a   Guinn, Brian E ^a   Furmanek, Stephen P ^a   Persaud, Annuradha K ^a   Raghuram, Anupama ^a   Fernandez, Francisco ^a   Beavin, Leslie ^a   Bosson, Rahel ^a   Fernandez Botran, Rafael ^b   Cavallazzi, Rodrigo ^a   Bordon, Jose ^c   Valdivieso, Claudia ^d   Schulte, Joann ^e   Carrico, Ruth M ^a   more..

^a University of Louisville School of Medicine   (United States)

^b Department of Pathology and Laboratory Medicine ^*  (United States)

^c Providence Hospital Washington DC   (United States)

^d Kentucky Transportation Cabinet   (United States)

^e Louisville Metro Department of Health and Wellness   (United States)

Author keywords

community acquired pneumonia; epidemiology; incidence; mortality

Indexed keywords

HYPERTENSIVE FACTOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOTHERMIA; INCIDENCE; INCOME; LEUKOPENIA; LOWEST INCOME GROUP; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; SMOKING; THORAX RADIOGRAPHY; UNITED STATES; COMMUNITY ACQUIRED INFECTION; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HEALTH SURVEY; LENGTH OF STAY; MICROBIOLOGY; PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; PNEUMONIA; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 85034814337     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix647     Document Type: Article

References (24)

1. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2016; 64(2):1-119.
2. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl 2):S27-72.
3. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157:1709-18.
4. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-63.
5. Jain S, Self WH, Wunderink RG, et al; CDC EPIC Study Team. Communityacquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373:415-27.
6. Ramirez JA. Fostering international multicenter collaborative research: the CAPO project. Int J Tuberc Lung Dis 2007; 11:1062-5.
7. Arnold FW, Summersgill JT, Lajoie AS, et al; Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175:1086-93.
8. Bordon J, Peyrani P, Brock GN, et al; CAPO Study Group. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008; 133:618-24.
9. United States Census Bureau. Geocoder. Available at: https://geocoding.geo.census. gov/geocoder. Accessed 17 November 2016.
10. Burton DC, Flannery B, Bennett NM, et al; Active Bacterial Core Surveillance/ Emerging Infections Program Network. Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health 2010; 100:1904-11.
11. Witzig R. The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med 1996; 125:675-9.
12. Centers for Disease Control and Prevention. The CDC health disparities and inequalities report-United States, 2011. MMWR Suppl 2011; 60:1-2. Available at: http://www.cdc.gov/mmwr/pdf/other/su6001.pdf. Accessed 17 November 2016.
13. World Health Organization. International statistical classification of diseases and related health problems, tenth revision. Geneva, Switzerland: WHO, 1992.
14. Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45:158-65.
15. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47:182-7.
16. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine 2009; 88:154-9.
17. Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 1999; 159:1550-5.
18. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169:910-4.
19. Bordon J, Wiemken T, Peyrani P, et al; CAPO Study Group. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010; 138:279-83.
20. Bruns AH, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 2011; 17:763-8.
21. Sandvall B, Rueda AM, Musher DM. Long-term survival following pneumococcal pneumonia. Clin Infect Dis 2013; 56:1145-6.
22. Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am J Respir Crit Care Med 2015; 192:597-604.
23. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014; 69 (suppl 1):S4-9.
24. Yende S, D'Angelo G, Kellum JA, et al; GenIMS Investigators. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177:1242-7.